Retrieve Medical Signs National Deal for $149 Passport

Retrieve Medical Holdings, Inc. (OTC: RMHI) announced on 8 October 2026 that it has signed a marketing agreement with a major U.S. financial services and membership platform to offer its Retrieve Passport℠ product directly to that platform's members. The company did not name the counterparty, did not disclose the agreement's financial terms, and did not state a contract duration or minimum volume commitment. Retrieve Passport is priced at $149 annually, a figure the company restated in the announcement.

The company called the arrangement its first national distribution relationship with a major financial services company. No revenue figure, member count, launch date or revenue-share split accompanied the disclosure.

Context — Why Does a Financial Platform Matter for Health Records?

Retrieve Medical frames the agreement as a distribution event rather than a product event. The company said the platform will offer Retrieve Passport to its members through its own programming, which places the product inside an existing consumer relationship instead of requiring Retrieve Medical to acquire subscribers one at a time.

That distinction matters for the unit economics of a $149 annual subscription. Customer acquisition cost is the dominant variable in direct-to-consumer health subscriptions, and a membership platform with an established billing relationship can absorb that cost. The company did not quantify what it pays the platform, if anything, for that access.

The report gives no prior-period comparable. Retrieve Medical disclosed no subscriber count, no revenue figure, no churn rate and no marketing spend, so there is no baseline against which to measure whether this agreement is incremental or transformative. The company also did not say whether the arrangement is exclusive, whether it covers all fifty states, or whether the platform's members will see the product as an opt-in benefit or a bundled feature.

Jerry Swon, the company's Chief Executive Officer, tied the deal to the company's stated mission. "People should be able to carry their medical history with them as easily as they carry their identification," he said, adding that the agreement creates a new distribution channel through a trusted national institution.

Retrieve Medical said the relationship supports a broader distribution strategy spanning consumer-membership, employer-benefit, affinity and healthcare-provider channels. Only the consumer-membership channel has a named counterparty as of this announcement.

Data — What the Numbers Show

Retrieve Passport carries a list price of $149 per year. That is the only financial figure the company disclosed in the announcement. The report contains no contract value, no minimum subscriber commitment, no revenue-share percentage, no expected launch date and no counterparty identity.

Disclosed	Not disclosed
Annual price: $149	Counterparty name
Product: Retrieve Passport	Contract value
Channel: consumer-membership	Launch date
Ticker: OTC: RMHI	Exclusivity terms

The absence of a launch date is the operational gap. A marketing agreement that has not been assigned a go-live date cannot be modeled into a revenue quarter, and the company did not indicate whether member access begins this quarter, next quarter or later.

For scale, $149 multiplied by any subscriber count the company has not published is arithmetic the company alone can perform. Without a disclosed member base for the platform, the addressable pool is unknowable from the report. The company also did not say what share of the $149 it retains after the platform's cut.

Retrieve Medical trades over the counter under RMHI. No market data accompanied the announcement.

Analysis — What It Means for Health-Tech Distribution

The strategic read is that consumer-controlled medical record aggregation is shifting from direct-to-consumer acquisition toward embedded distribution. Retrieve Passport pulls records from doctors, hospitals, emergency rooms and laboratories through nationwide health information exchange networks, then uses artificial intelligence to render them in plain language. Subscribers reach the profile through a digital dashboard and a QR-enabled emergency access card.

That product requires two things a startup rarely has: integration with health information exchanges, and a reason for a healthy person to pay annually. A financial services membership platform solves the second problem. The company said the card and dashboard support use cases including new physician visits, chronic condition management, caregiving for an aging parent and travel.

The limitation is verification. An unnamed counterparty cannot be checked, and a marketing agreement is not a binding revenue commitment. The report does not say whether the platform is obligated to promote the product, whether it receives a commission, or whether either side can terminate early. Investors have no way to size the deal from the disclosure.

Positioning follows from that opacity. The announcement gives momentum traders a headline and gives fundamental investors nothing to underwrite. Until the company names the platform or reports subscription revenue, the agreement sits in the category of unquantified corporate news.

Outlook — What to Watch Next

Three things would convert this announcement into a measurable event. First, disclosure of the platform's identity, which would let observers gauge the size of the member base. Second, a stated launch date, which would place the revenue in a specific quarter. Third, any subsequent filing that reports subscription counts or revenue attributable to the channel.

Retrieve Medical has not scheduled an earnings date in the announcement and gave no guidance. The company's stated broader strategy spans employer-benefit, affinity and healthcare-provider channels, so additional distribution announcements are the pattern to monitor.

The product's $149 annual price is the only level the report establishes. Any subscriber figure the company later publishes can be checked against it directly.

Frequently Asked Questions

What does the Retrieve Medical agreement mean for retail investors?

It is a distribution announcement without financial terms. The company did not name the platform, disclose contract value, or state when members can sign up. For a retail investor, that means the deal cannot be sized from the announcement alone. What would change the picture is a named counterparty, a launch date, or a later filing showing subscription revenue from the channel.

Why did Retrieve Medical not name the financial services platform?

The report does not explain the omission. Commercial agreements often include confidentiality provisions that prevent one party from naming the other before a joint launch, but the company did not state that as the reason. What the report does confirm is that the counterparty is described as a major U.S. financial services and membership platform with a substantial national consumer footprint.

What happens next for Retrieve Passport subscribers?

Nothing is scheduled. The company said the platform will offer Retrieve Passport to members through its programming but gave no launch date, no enrollment process and no indication of whether the product appears as an opt-in benefit or a bundled feature. Existing subscribers access records through the digital dashboard and the QR-enabled emergency access card at the $149 annual price.

Bottom Line

Retrieve Medical has a national distribution partner it will not name and terms it will not disclose, leaving the $149 product's reach unquantifiable.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.